U.S. Markets open in 3 hrs 39 mins

Biosimilar competition to AbbVie’s Humira is eroding profits, but company says it has confidence in pipeline

Sarah Toy
Biosimilar competition to AbbVie’s Humira is eroding profits, but company says it has confidence in pipeline

AbbVie executives sought to reassure investors during a Wednesday call that its pipeline will more than plug up any holes that biosimilars might leave.